Bayer’s stroke drug wins fast-track review in US after cutting repeat stroke risk by 26%
The development comes as stroke remains one of the world’s biggest health threats
The development comes as stroke remains one of the world’s biggest health threats
Millions of stroke survivors across the world may soon have a new defense
Subscribe To Our Newsletter & Stay Updated